(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

APTAR PHARMA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

APTAR PHARMA

ST13

US500000079361471

Classe

8, 9, 17, 20, 35, 42, 44

Pedido

79361471

Registro

7646295

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

42

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

8, 9, 17, 20, 35, 42, 44

Data de depósito

03/06/2022

Data de registro

14/01/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/01/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

FR

Examinador

HARMON, RAYMOND E

Unidade examinadora

L30

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

APTAR FRANCE SAS

Representantes

Ben Natter Haug Partners, LLP

Classificação técnica

Classes Nice

Classe 8Classe 9Classe 17Classe 20Classe 35Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 8

Hand-operated pumps for ejecting medical and pharmaceutical preparations from receptacles and containers; Hand-operated hand tools and implementshand-operated pumps for ejecting medical and pharmaceutical preparations from receptacles and containers

Classe 9

Downloadable and recorded software for monitoring health; Downloadable and recorded software for managingtracking and monitoring the taking of prescription medicationsmanagingtracking and monitoring healthcare treatments in the nature of injectable medicationsnasal medicationsdermally delivered medicationsrespiratory drugs for use in the medical field; downloadable and recorded software for reminding and delivering drug treatments to patients and providing information for schedulingreporting and monitoring treatment side effectsproviding educational contents and improving communication with their healthcare teams for medical use; data processing equipment

Classe 17

Rubber lids and caps for industrial packaging containers; Rubber sealing elementsrubber seals for jarssealing plugs made primarily from rubberrubber bottle stoppers; rubber stoppers for bottles for medical use; rubber stoppers for bottles for medicine containers; rubber stoppers for bottles for use with medical pharmaceutical infusionsfor antibioticsfor conditioning of liquidsgasespowders and freeze-dried products; valves of synthetic rubber

Classe 20

Plastic packaging components for medical packaging containers and for commercial packaging in the nature of dispensing and closable pour spouts and container and carton closures; Valves not of metalnon-metal valves for containers being aerosol dispensers for medical pharmaceutical use; Plastic containers for commercial packaging in the nature of bottlessqueeze tubesjarsspray pumps.

Classe 35

Business to business wholesale ordering services for devices for medical use; business to business wholesale ordering services for pharmaceutical products being pharmaceutical preparations; business to business wholesale ordering services for medical supplies; all the aforesaid services provided exclusively between professionalsto healthcare industries and not for retail purposes

Classe 42

Design and development of devices for medical use; software design; design and development of pharmaceutical products; engineering services in the pharmaceutical field; research and development services for the pharmaceutical industry; design of packaging and wrapping materials

Classe 44

Medical consultation; medical clinic services

Publicações

Histórico de despachos e eventos da marca no USPTO.

42 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/08/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

13/07/2025

FIMP

FINAL DISPOSITION PROCESSED

13/07/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

14/04/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

14/01/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

14/01/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/11/2024

PUBO

PUBLISHED FOR OPPOSITION

26/11/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

20/11/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/10/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/10/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

19/08/2024

GNRT

NON-FINAL ACTION E-MAILED

19/08/2024

CNRT

NON-FINAL ACTION WRITTEN

19/08/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

15/08/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

03/08/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/07/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/07/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

28/05/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/05/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/05/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/05/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

13/05/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

20/11/2023

GNFR

FINAL REFUSAL E-MAILED

20/11/2023

CNFR

FINAL REFUSAL WRITTEN

20/11/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

19/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

19/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/10/2023

RFNT

REFUSAL PROCESSED BY IB

06/06/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/05/2023

RFRR

REFUSAL PROCESSED BY MPU

12/05/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

23/03/2023

CNRT

NON-FINAL ACTION WRITTEN

22/03/2023

DOCK

ASSIGNED TO EXAMINER

20/03/2023

MAFR

APPLICATION FILING RECEIPT MAILED

07/02/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/02/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace APTAR PHARMA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.